PEDIAPHARM NAPROXEN SUSPENSION
MEDEXUS PHARMACEUTICALS INC.
Quick answers
Is there a shortage of PEDIAPHARM NAPROXEN SUSPENSION in Canada?
No. There is no current shortage of PEDIAPHARM NAPROXEN SUSPENSION 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NAPROSYN 375MG
SYNTEX INC.
RATIO-NAPROXEN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
SYNFLEX TAB 275MG
ALTIMED PHARMA INC.
ANAPROX
SYNTEX INC.
NAPROSYN 250MG
SYNTEX INC.
ANAPROX DS TAB 550MG
SYNTEX INC.
DIN
02162431
Strength
25MG
Dosage Form
Suspension
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MEDEXUS PHARMACEUTICALS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
1MG · DIN 02469332
1.5G · DIN 02504928
7.5MG · DIN 02320029
25MG · DIN 02454874
10MG · DIN 02454831
15MG · DIN 02454858
22.5MG · DIN 02454777
12.5MG · DIN 02454750
17.5MG · DIN 02454769
20MG · DIN 02454866
DIN 02459655
100% · DIN 02346672